The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response

被引:19
作者
Djoumerska-Alexieva, Iglika [1 ]
Pashova, Shina [1 ]
Vassilev, Tchavdar [1 ]
Pashov, Anastas [1 ]
机构
[1] Bulgarian Acad Sci, Stefan Angelov Inst Microbiol, Dept Immunol, BU-1113 Sofia, Bulgaria
关键词
Intravenous immunoglobulins; B1; lymphocytes; CD93; Innate response activator B1 cells; Ferrous ions; Sepsis; ANTIGEN-BINDING; DNA ANTIBODIES; POLYREACTIVITY; AUTOANTIBODIES; EXPOSURE; AGENTS; TLR4; IGG;
D O I
10.1016/j.autrev.2012.10.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intravenous immunoglobulin preparations (IVIg) that have undergone a mild oxidizing treatment with ferrous ions have an increased polyspecificity, which is not associated with a higher propensity to form aggregates. Among other biological properties of the modified IVIg, a protective effect in LPS sepsis model stands out as the native preparation is totally devoid of it or even exacerbates sepsis. A recent finding identified an LPS induced subset of B1 lymphocytes that migrate from the peritoneal cavity to the spleen acquiring the expression of CD93, GM-CSF as well as the capacity to control sepsis. This report demonstrates that modified IVIg, but not the native preparation, causes a further increase in this population during LPS sepsis. Partial targeted suppression of the peritoneal B cell proliferation by an intracellular dye abrogates this effect and the clinical benefit of modified IVIg. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:653 / 656
页数:4
相关论文
共 22 条
  • [21] Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins
    St-Amour, Isabelle
    Laroche, Andre
    Bazin, Renee
    Lemieux, Real
    [J]. CLINICAL IMMUNOLOGY, 2009, 133 (01) : 52 - 60
  • [22] Natural Hidden Autoantibodies to Tissue Transglutaminase Cross-React with Fibrinogen
    Zoeller-Utz, Ingrid M.
    Esslinger, Birgit
    Schulze-Krebs, Anja
    Dieterich, Walburga
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (02) : 204 - 212